January 2026
The global human papillomavirus Hpv vaccines market size was evaluated at USD 9.73 billion in 2025 and is predicted to hit around USD 29.63 billion by 2035, growing at a CAGR of 11.78%.
September 2026
The global automotive human machine interface market size is projected to hit around USD 80.13 billion by 2034 from USD 32.97 billion in 2026 with a CAGR of 11.79%.
September 2026
The global military and humanitarian trauma care market size is estimated to hit around USD 15.27 billion by 2035 increasing from USD 8.56 billion in 2026, with a CAGR of 6.65%.
September 2026
The pediatric vaccines market size was valued at USD 70.38 billion in 2026 and is expected to attain around USD 117.32 billion by 2035 with a CAGR of 5.86%.
September 2026
The virtual humans market size reached USD 5.76 billion in 2026, with leading virtual humans market companies including Striver, PIXO VR, Talespin.
September 2026
The global human augmentation market size was valued at USD 376.67 billion in 2024 and is projected to surpass around USD 1,390.01 billion by 2034, with a CAGR of 13.95%.
September 2026
The global human capital management market size is projected to surpass around USD 81.41 billion by 2035 from USD 34.37 billion in 2025 with a notable CAGR of 9.01%%.
September 2026
The global human high-density lipoprotein (Human HDL) market size is estimated to hit around USD 345.90 billion by 2035 increasing from USD 119.84 billion in 2026, with a CAGR of 12.50%.
September 2026
The global human biospecimens market size was evaluated at USD 14.45 billion in 2026 and is predicted to hit around USD 26.45 billion by 2034, growing at a CAGR of 7.85%.
September 2026
The human centric lighting market size stood at USD 7.23 billion in 2026, with major human centric lighting market companies including Cree Lighting USA LLC, Eaton Corporation, Fagerhults Belysning AB, Helvar, Hubbell Lighting, LEDVANCE GmbH.
September 2026
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
September 2026
The global inactivated vaccines market size is estimated to hit around USD 79.02 billion by 2035 increasing from USD 45.44 billion in 2025, with a CAGR of 5.69%.
September 2026
The human machine interface market size stood at USD 7.41 billion in 2026, with major human machine interface market companies including ABB Ltd., Advantech Co. Ltd., Panasonic Corporation, Atmel Corporation
August 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
August 2026
The global humanoid robot market size is calculated at USD 1.84 billion in 2025 and is projected to hit around USD 8.78 billion by 2035 with a CAGR of 16.91%.
August 2026
The global human microbiome market size was calculated at USD 309.17 million in 2025 and is projected to hit around USD 2,764.97 million by 2035 with a CAGR of 24.49%.
July 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
June 2026
The global human fibrinogen concentrates market size is evaluated at USD 1.33 billion in 2025 and is predicted to hit around USD 2.66 billion by 2035, growing at a CAGR of 7.18%.
June 2026
The global human primary cell culture market size was estimated at USD 4.33 billion in 2025 and is expected to hit around USD 12.21 billion by 2035, growing at a CAGR of 10.92% from 2026 to 2035.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
May 2026
The global human PBMC isolation kit market size is estimated to hit around USD 365.89 million by 2035 from USD 176.77 million in 2026, with a CAGR of 8.43%.
April 2026
The global aquaculture vaccines market size is calculated at USD 553.40 million in 2025 and is projected to hit around USD 1,124.65 million by 2035 with a CAGR of 8.27% from 2026 to 2035.
April 2026
The global human osteoblasts market size was evaluated at USD 51.86 million in 2025 and is projected to reach around USD 95.96 million by 2035, with a CAGR of 6.35%.
April 2026
The global vaccines market size reached USD 91.97 billion in 2025 and is predicted to hit around USD 170.60 billion by 2035, growing at a notable CAGR of 6.37%.
March 2026
The global human nutrition market size was valued at USD 463.13 billion in 2025 and it is projected to reach around USD 864.10 billion by 2035 with a CAGR of 6.44%.
February 2026
The global fixed human anesthesia workstation market size was evaluated at USD 1.72 billion in 2025 and is predicted to hit around USD 3.63 billion by 2035, growing at a CAGR of 7.74%.
February 2026
The global brucellosis vaccines market size is valued at USD 266.78 million in 2025 and is expected to attain around USD 424.75 million by 2035 with a CAGR of 4.76%.
February 2026
The global canine vaccines market size was evaluated at USD 2.05 billion in 2025 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 7.51%.
January 2026
The canada human fibrinogen concentrates market size was evaluated at USD 159.6 million in 2025 and is predicted to hit around USD 329.39 million by 2035, growing at a CAGR of 7.51%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com